(Press-News.org) The liver is not only the largest internal organ but also vital for human life as a metabolic center. It also possesses remarkable self-healing powers: even when large portions are removed, such as during surgery, they quickly regenerate in healthy individuals. However, in cases of repeated or chronic injury to the liver tissue, as caused by excessive alcohol consumption or viral hepatitis, this regenerative capacity fails. Scarring occurs, known as fibrosis, where liver cells are replaced by fibrous tissue. The liver hardens and becomes increasingly unable to perform its functions - in the worst case, this leads to liver failure.
To better understand the scarring process, a research team led by Thomas Reiberger, Professor of Gastroenterology and Hepatology at MedUni Vienna and Adjunct Principal Investigator at CeMM, examined gene activity in two different mouse models exhibiting varying degrees of liver disease severity, also capturing certain phases of spontaneous regression of the disease. At the same time, important indicators of disease severity, such as portal venous pressure, blood markers of liver injury, or the extent of liver fibrosis based on liver tissue samples, were recorded. The results were published in the journal iScience (DOI: 10.1016/j.isci.2024.109301).
Dynamic molecular processes can reverse liver fibrosis
A highly dynamic pattern of gene expression was observed, both during the development of fibrosis and, interestingly, also during the regression of liver fibrosis. Some genes were upregulated during the progression of the disease and downregulated during regression, while for others, it was the opposite. However, a number of genes showed persistent expression changes even during the regression phase, indicating long-lasting effects of liver damage. Using state-of-the-art bioinformatics methods, these genetic patterns were linked to the disease indicators described above. In doing so, the researchers identified genetic drivers of the disease that have potential as targets for the development of future therapies.
Through specially developed network algorithms, four important groups of genes were identified, which could be linked to the dynamics of fibrosis, portal venous pressure, histological data, and blood markers. These so-called "hub" genes could all be further developed into clinically relevant biomarkers. This was also tested and confirmed in the study with datasets from patients with liver diseases. In collaboration with researchers from the University of Strasbourg and the Institut Universitaire de France, some of the "hub" genes were also confirmed in patients who were cured of hepatitis C, and thus had a regressed liver disease.
The present study reveals genetic mechanisms in the development of liver fibrosis and offers new therapeutic possibilities to intervene in these mechanisms. Further studies are needed to fully understand the potential of the hub genes and to use them for therapeutic strategies focusing on the regression of liver fibrosis - especially in patients with liver cirrhosis who adhere to alcohol abstinence or have been cured of viral hepatitis.
***
The Study “Transcriptomic signatures of progressive and regressive liver fibrosis and portal hypertension” was published in iScience on March 15, 2024. DOI: 10.1016/j.isci.2024.109301
Authors: Oleksandr Petrenko, Philipp Königshofer, Ksenia Brusilovskaya, Benedikt S. Hofer, Katharina Bareiner, Benedikt Simbrunner, Frank Jühling, Thomas F. Baumert, Joachim Lupberger, Michael Trauner, Stefan G. Kauschke, Larissa Pfisterer, Eric Simon, André F. Rendeiro, Laura P.M. H. de Rooij, Philipp Schwabl, Thomas Reiberger
Funding: Thomas Reiberger received funding from the Austrian Federal Ministry for Digital and Economic Affairs, the National Foundation for Research, Technology and Development, Boehringer Ingelheim, and the Christian Doppler Research Association.
The CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences is an international, independent and interdisciplinary research institution for molecular medicine under the scientific direction of Giulio Superti-Furga. CeMM is oriented towards medical needs and integrates basic research and clinical expertise to develop innovative diagnostic and therapeutic approaches for precision medicine. Research focuses on cancer, inflammation, metabolic and immune disorders, and rare diseases. The Institute's research building is located on the campus of the Medical University and the Vienna General Hospital.
The Medical University of Vienna (MedUni Vienna) is one of the longest-established medical education and research facilities in Europe. With almost 8,000 students, it is currently the largest medical training centre in the German-speaking countries. With more than 6,000 employees, 30 departments and two clinical institutes, twelve medical theory centres and numerous highly specialised laboratories, it is one of Europe's leading research establishments in the biomedical sector. MedUni Vienna also has a medical history museum, the Josephinum..
www.meduniwien.ac.at
For further information please contact:
Stefan Bernhardt
PR & Communications Manager
CeMM
Research Center for Molecular Medicine of the Austrian Academy of Sciences
Lazarettgasse 14, AKH BT 25.3
1090 Vienna, Austria
Phone +43-1/40160-70 056
Fax +43-1/40160-970 000
sbernhardt@cemm.at
www.cemm.at
END
New insights could improve treatment of liver fibrosis
2024-03-15
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Women involved in car crashes may be more likely to go into shock than men
2024-03-15
It is well known that car safety equipment was originally designed with male-representative bodies in mind. This means women sitting in the front row are more likely to suffer severe or fatal injuries in the case of a crash. They are also more likely to be trapped in crashed cars.
Interested in the inequalities of car design and the resulting injuries, a team of researchers in the US has used trauma injury data from car crash victims to evaluate differences in injury patterns typical for males and females.
“We found that vehicle crash injury patterns and injury severity differ between men and women. We also show that women are arriving ...
Researchers attempt to clarify correlation between strain and catalytic activities for 2D catalysts
2024-03-15
Researchers led by Prof. WANG Bin at National Center for Nanoscience and Technology (NCNST) of the Chinese Academy of Sciences recently reported that strain generated at bubbles of 2D materials can benefit the catalytic activity of the hydrogen evolution reaction (HER). The study was published in Chem Catalysis.
Green hydrogen produced by electrochemical water splitting offers the potential to achieve carbon-neutral production processes. Catalysts play a crucial role in facilitating HER at the anode, making it a key component in the transition to a sustainable energy future. Transition metal dichalcogenides (TMDs), particularly MoS2, have drawn attention ...
A theory linking ignition with flame provides roadmap to better combustion engines
2024-03-15
In a study published on January 18, 2024 in the journal Physics of Fluids, researchers from Tohoku University theoretically linked ignition and deflagration in a combustion system, unlocking new configurations for stable, efficient combustion engines due to the possible existence of any number of steady-state solutions.
"This research directly tackles the challenge of reducing carbon dioxide emissions by enhancing the efficiency of combustion engines, a significant source of these emissions," said Youhi Morii from the ...
Doping engineering in halide perovskite, an efficient synthesis method of white LEDs
2024-03-15
In 1879, Edison invented the incandescent lamp, which brought light to the night. In 1969, the first red light emitting diodes (LEDs) lamp came out. However, as the key to making white light bulbs, high-energy blue light has not been successfully commercialized. Until 1998, the Japan’s Nakamura Shoji made white LEDs, which marked the official entry of LEDs into the lighting era. LEDs have the advantages of high efficiency, environmental protection and energy saving. Metal halide perovskites (MHPs) have become a powerful candidate for new LEDs ...
Parallel physical random bit generation towards rates of order 100 Tb/s
2024-03-15
In our digital networked society, random bit generators (RBGs) are vital for services and state-of-the-art technologies such as cryptographically secured communication, blockchain technologies, and quantum key distribution. An ever-increasing demand to improve the security of digital information has shifted the generation of random bits from sole reliance on pseudorandom algorithms to the use of physical entropy sources. Shannon’s theorem establishes that it is required for the ultimate security to achieve bit rate matching that of the true RBGs with that of the communication systems. For this purpose, optical chaos has been widely studied in the past decades as a means for the ...
The Lancet Neurology: Neurological conditions now leading cause of ill health and disability globally, affecting 3.4 billion people worldwide
2024-03-15
Peer-reviewed / Modelling study / People
Embargoed access to the paper and contact details for authors are available in Notes to Editors at the end of the release.
Most comprehensive study to date finds the burden of nervous system (neurological) conditions is much greater than previously understood, with this diverse group of conditions affecting 43% of the world’s population (3.4 billion individuals) in 2021.
Neurological conditions were responsible for 443 million years of healthy life lost due to illness, disability, and premature death (disability-adjusted life years) in 2021, making them the ...
Study of long-term student engagement challenges “one great teacher” narrative of education
2024-03-15
A positive relationship with a teacher at an early age may help children to feel more engaged with school, but not necessarily in the long term, new research shows.
The finding comes from a University of Cambridge study of more than 3,600 young people in Australia, using data gathered at several points between the ages of eight and 15. The students’ levels of school engagement – meaning their interest in school and willingness to learn – fluctuated during this period, especially during the ...
UChicago Medicine helps bring first-of-its-kind drug for metabolic liver disease to the clinic
2024-03-15
Liver disease specialists at the University of Chicago Medicine will soon begin prescribing a first-of-its-kind drug for treating advanced metabolic dysfunction-associated steatotic liver disease (MASLD) — formerly known as nonalcoholic fatty liver disease (NAFLD).
Resmetirom (to be sold under the brand name Rezdiffra), received FDA approval on March 14, 2024. It is the first medication approved for treating metabolic dysfunction-associated steatohepatitis (MASH), a more advanced stage of MASLD characterized by liver inflammation and scarring known as fibrosis.
“Until now, liver disease has ...
Long COVID ‘indistinguishable’ from other post-viral syndromes a year after infection
2024-03-14
**Note: the release below is a special early release from the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, Spain, 27-30 April). Please credit the congress if you use this story**
Long COVID appears to manifest as a post-viral syndrome indistinguishable from seasonal influenza and other respiratory illnesses, with no evidence of increased moderate-to-severe functional limitations a year after infection, according to new research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in ...
Improved neuromonitoring could prevent brain injuries for patients on ECMO life support
2024-03-14
Extracorporeal membrane oxygenation (ECMO) can be a life-saving therapy for patients with acute heart or lung failure. During ECMO therapy, a patient’s blood flows out of their veins through tubes and into a machine that does both the actions of the heart and lungs. The oxygenated blood is then returned to the body allowing the heart and lungs to rest.
While ECMO can stabilize a critically ill patient in an intensive care unit, the procedure carries significant risks, including brain injury. Often these patients are comatose, and current neuromonitoring techniques are too risky and invasive to perform routinely. Now, researchers at the University ...